SCHEMBL3844501

SCHEMBL3844501

CCOC(=O)C(C)(C)Sc1cccc(OCCCNCCCCCCCc2nn(C)c(=O)n(C)c2=O)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.35
GAA P10253 2/20 0.35
ALDH1A1 P00352 1/20 0.35
CYP2D6 P10635 2/20 0.35
MAPK1 P28482 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C19 P33261 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
KMT2A Q03164 1/20 0.34
PPARG P37231 1/20 0.34
PPARA Q07869 1/20 0.34
POLB P06746 1/20 0.34
DRD2 P14416 2/20 0.33
DRD4 P21917 2/20 0.33
LTA4H P09960 1/20 0.33
TP53 P04637 1/20 0.33
DRD3 P35462 1/20 0.32
FAAH O00519 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3840687 0.98 POLB (0.36) KDM4EGAAALDH1A1CYP2D6MAPK1
SCHEMBL3842937 0.90 LTA4H (0.36) KDM4EALDH1A1SMN1; SMN2KMT2APOLB
SCHEMBL3840686 0.80 MAPK1 (0.34) GAACYP2D6MAPK1SMN1; SMN2MAOA
SCHEMBL3284699 0.78 THRA (0.36) CYP2D6MAOAMAOBPPARGPPARA
SCHEMBL3291240 0.78 PPARA (0.35) CYP2D6MAOAMAOBPPARGPPARA
SCHEMBL3286825 0.76 PPARA (0.36) KDM4EALDH1A1SMN1; SMN2MAOAMAOB
SCHEMBL3287365 0.76 PPARA (0.36) KDM4EALDH1A1SMN1; SMN2MAOAMAOB
SCHEMBL3845617 0.74 PPARA (0.42) CYP1A2PPARGPPARA
SCHEMBL3292854 0.71 PPARA (0.42) KDM4EALDH1A1CYP2D6CYP2C19MAOA
SCHEMBL3842934 0.70 SLC2A1 (0.38) MAPK1SMN1; SMN2PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1856065-B1 1,2,4-TRIAZINE DERIVATIVES, PREPARATION AND USE THEREOF IN HUMAN THERAPY PF MEDICAMENT (FR) 2009-11-11 EP claimed